Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Western Blot: Monkeypox Virus A35 Antibody [NBP3-23475] - NBP3-23475 at 1:2000 dilution. Lane A: Monkeypox Virus A35 5ng. Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-23475_rabbit-monkeypox-virus-a35-pab-1362024223414.png "Western Blot: Monkeypox Virus A35 Antibody [NBP3-23475] - NBP3-23475 at 1:2000 dilution. Lane A: Monkeypox Virus A35 5ng. Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")
![NBP3-18811 used at 1:1000 dilution. Lane A: Monkeypox Virus A35 Protein 10ng. Lane B: Vaccinia virus (VACV) (strain Copenhagen) A33R Protein 10ng. Secondary Goat Anti-Mouse IgG (H+L)[HRP] used at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-18811_mouse-monkeypox-virus-a35-mab-0017-45202316461421.png "NBP3-18811 used at 1:1000 dilution. Lane A: Monkeypox Virus A35 Protein 10ng. Lane B: Vaccinia virus (VACV) (strain Copenhagen) A33R Protein 10ng. Secondary Goat Anti-Mouse IgG (H+L)[HRP] used at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")
![Western Blot: Monkeypox Virus A35 Antibody (0026) [NBP3-18812] - Each lane was blotted with NBP3-18812 at 1:1000 dilution, Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution as a secondary. Developed using the ECL technique under reducing conditions. Lane A: Monkeypox Virus A35R (NBP3-18228) 10ng. Lane B: Vaccinia virus (strain Copenhagen) A33R Protein 10ng](http://images.novusbio.com/fullsize/Monkeypox-Virus-A35-Antibody-0026-Western-Blot-NBP3-18812-img0001.jpg "Western Blot: Monkeypox Virus A35 Antibody (0026) [NBP3-18812] - Each lane was blotted with NBP3-18812 at 1:1000 dilution, Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution as a secondary. Developed using the ECL technique under reducing conditions. Lane A: Monkeypox Virus A35R (NBP3-18228) 10ng. Lane B: Vaccinia virus (strain Copenhagen) A33R Protein 10ng")